Description

You will lead the economic modeling strategy for a late-stage clinical oncology company, developing health economic models to support HTA submissions and payer access. This role offers the opportunity to shape patient care in oncology by providing robust evidence for targeted therapies.

Requirements

• Advanced degree (Masters or PhD) in health economics, econometrics, biostatistics, mathematics, engineering or related field
• 15+ years with Masters (13+ with PhD/PharmD/DrPH) of relevant economic modeling experience in pharma, biotech, or consulting
• Hands-on experience developing cost-effectiveness, budget impact models, and NMA/MAIC
• Track record of high impact publications in economic modeling for global access decision-makers
• Experience supporting HTA submissions and payer evidence generation

Responsibilities

• Lead development of strategic and operational plans for health economic modeling across portfolio
• Partner with Global HEOR RWE Executive Directors on core economic modeling plans for HTA and payer submissions
• Provide strategic and methodological leadership for local HTA adaptations of economic models
• Lead approach to monitor and integrate evolving HTA guidelines and payer requirements
• Represent company in external working groups on modeling standards and innovation